Abstract:Zika virus (ZIKV), a single-strand RNA flavivirus, is transmitted primarily through Aedes aegypti. The recent outbreaks in America and unexpected association between ZIKV infection and birth defects have triggered the global attention. This vouches to understand the molecular mechanisms of ZIKV infection to develop effective drug therapy. A systems-level understanding of biological process affected by ZIKV infection in fetal brain sample led us to identify the candidate genes for pharmaceutical intervention and potential biomarkers for diagnosis. To identify the key genes, transcriptomics data (RNA-Seq) with GSE93385 of ZIKV (Strain: MR766) infected human fetal neural stem cell are analyzed. In total, 1,084 differentially expressed genes (DEGs) are identified, that is, 471 upregulated and 613 downregulated genes. Further analysis such as the gene ontology term suggested that the downregulated genes are mostly enriched in defense response to virus, receptor binding, laminin binding, extracellular matrix, endoplasmic reticulum, and for upregulated DEGs: translation initiation, RNA binding, cytosol, and nucleosome are enriched. And through pathway analysis, systemic lupus erythematosus (SLE) is found to be the most enriched pathway. Protein-protein interaction (PPI) network is constructed to find the hub genes using STRING database. The seven key genes namely cyclin-dependent kinase 1 (CDK1), cyclin B1 (CCNB1), histone cluster 1 H2B family member K, (HIST1H2BK) histone cluster 1 H2B family member O (HIST1H2BO), and histone cluster 1 H2B family member B (HIST1H2BB), polo-like kinase 1 (PLK1), and cell division cycle 20 (CDC20) with highest degree are found to be hub genes using Centiscape, a Cytoscape plugin. The modules of PPI network using Molecular Complex Detection plugin are found significant in structural constituent of ribosome, defense response to virus, nucleosome, SLE, extracellular region, and regulation of gene silencing. Thus, identified key hub genes and pathways shed light on molecular mechanism that may contribute to the discovery of novel therapeutic targets and development of new strategies for the intervention of ZIKV disease.

Chemical Proteomics Tracks Virus Entry and Uncovers NCAM1 As Zika Virus Receptor

Single cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells

Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells

Discovery And Computational Analyses Of Novel Small Molecule Zika Virus Inhibitors

Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles

Characterization of Two Highly Specific Monoclonal Antibodies Targeting the Glycan Loop of the Zika Virus Envelope Protein

High-throughput crystallographic fragment screening of Zika virus NS3 Helicase

Crystallographic fragment screening delivers diverse chemical scaffolds for Zika virus NS2B-NS3 protease inhibitor development

An Integrated Systems Biology Approach Identifies the Proteasome as A Critical Host Machinery for ZIKV and DENV Replication

Identification of Hub Genes and Pathways in Zika Virus Infection Using RNA-Seq Data: A Network-Based Computational Approach

Production, Titration and Imaging of Zika Virus in Mammalian Cells

Recent advances in the study of zika virus structure, drug targets, and inhibitors

Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc γ Receptor-Dependent and -Independent Pathways

Identification and Characterization of Key Residues in Zika Virus Envelope Protein for Virus Assembly and Entry

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus

A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development

Investigating human monocyte adhesion, migration and transmigration and their modulation by Zika virus

Molecular Mechanism of Divalent-Metal-induced Activation of NS3 Helicase and Insights into Zika Virus Inhibitor Design.

Analysis of Viral RNA-host Protein Interactomes Enables Rapid Antiviral Drug Discovery

Delineating Antibody Recognition Against Zika Virus During Natural Infection.